Continuous dopamine-receptor stimulation in advanced Parkinson's disease

被引:134
|
作者
Nutt, JG [1 ]
Obeso, JA
Stocchi, F
机构
[1] Oregon Hlth Sci Univ, Dept Neurol, Portland, OR 97201 USA
[2] Univ Navarra, Dept Neurol, E-31080 Pamplona, Spain
[3] Univ La Sapienza, Prima Clin Neurol, I-00185 Rome, Italy
关键词
D O I
10.1016/S1471-1931(00)00029-X
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Intermittent or pulsatile dopamine-receptor stimulation is postulated to induce plastic changes in motor systems that are responsible for the development of the motor fluctuations and dyskinesia that complicate long-term L-dopa therapy of Parkinson's disease. As a corollary to this hypothesis, continuous dopamine-receptor stimulation can avoid or reverse these complications. Such continuous stimulation is unlikely to mimic completely the normal function of the dopaminergic system, but should avoid the supra-physiological swings in extracellular dopamine that accompany intermittent L-dopa dosing. The concern is that this continuous stimulation might induce tolerance rather than sensitization to some effects of L-dopa. Open clinical trials support the value of continuous dopaminergic stimulation in Parkinson's disease with established motor complications, but rigorous studies, although experimentally difficult, are needed.
引用
收藏
页码:S109 / S115
页数:7
相关论文
共 50 条
  • [31] EFFECT OF DOPAMINE-RECEPTOR BLOCKADE ON STIMULATION-INDUCED FEEDING
    STREATHER, A
    BOZARTH, MA
    PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR, 1987, 27 (03) : 521 - 524
  • [32] DOPAMINE-RECEPTOR IMAGING
    FRIBERG, L
    CEPHALALGIA, 1993, 13 (05) : 307 - 307
  • [33] Continuous Dopaminergic Stimulation Improves Cortical Maladaptive Changes in Advanced Parkinson's Disease
    Kolmancic, Kaja
    Zupancic, Nina K.
    Trost, Maja
    Flisar, Dusan
    Kramberger, Milica G.
    Pirtosek, Zvezdan
    Kojovic, Maja
    MOVEMENT DISORDERS, 2022, 37 (07) : 1465 - 1473
  • [34] DOPAMINE-RECEPTOR PHARMACOLOGY
    SEEMAN, P
    VANTOL, HHM
    TRENDS IN PHARMACOLOGICAL SCIENCES, 1994, 15 (07) : 264 - 270
  • [35] AUTO-IMMUNE RESPONSE TO DOPAMINE-RECEPTOR AS A POSSIBLE MECHANISM IN PATHOGENESIS OF PARKINSON DISEASE AND SCHIZOPHRENIA
    ABRAMSKY, O
    LITVIN, Y
    PERSPECTIVES IN BIOLOGY AND MEDICINE, 1978, 22 (01) : 104 - 114
  • [36] DOPAMINE-RECEPTOR SUPERSENSITIVITY
    KOSTRZEWA, RM
    NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS, 1995, 19 (01): : 1 - 17
  • [37] Dopamine Agonist Therapy in Advanced Parkinson's Disease
    Reichmann, Heinz
    JOURNAL OF MOVEMENT DISORDERS, 2009, 2 (01) : 10 - 13
  • [38] DOPAMINE-RECEPTOR STIMULANTS IN THE TREATMENT OF PARKINSONS-DISEASE
    RINGWALD, E
    HIRT, D
    MARKSTEIN, R
    VIGOURET, JM
    NERVENARZT, 1982, 53 (02): : 67 - 71
  • [39] DOPAMINE-RECEPTOR FAMILIES AND THE TREATMENT OF PARKINSONS-DISEASE
    BEDARD, PJ
    GOMEZMANCILLA, B
    BLANCHET, P
    GRONDIN, R
    DIPAOLO, T
    CLINICAL NEUROPHARMACOLOGY, 1995, 18 : S178 - S187
  • [40] The response of subthalamic nucleus neurons to dopamine receptor stimulation in a rodent model of Parkinson's disease
    Kreiss, DS
    Mastropietro, CW
    Rawji, SS
    Walters, JR
    JOURNAL OF NEUROSCIENCE, 1997, 17 (17): : 6807 - 6819